482 Results (Page 19 of 20)
US Markets Research Reports
US Graft-versus-Host Disease (GvHD) Therapeutics Market Analysis
The US GvHD Therapeutics Market was valued at $1050 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $1589.27 Mn by 2030. The drivers responsible for the growth of this market are the rising incidence of GvHD, advanced treatments, patient-centric treatments, and growing awareness. The competition in the market prevails among players like GSK, Abbott, Takeda, Genzyme, Sanofi, Eli Lily, Mallinckrodt and others.
US Central Nervous System (CNS) Therapeutics Market Analysis
The US Central Nervous System (CNS)Therapeutics Market was valued at $88.2 Bn in 2022 and is predicted to grow at a CAGR of 4.4% from 2023 to 2030, to $124.472 Bn by 2030. The key drivers of this industry include the rising prevalence of CNS diseases, untapped market potential, and technological advancements in the industry. The industry is primarily dominated by players such as Pfizer, Novartis, Teva Pharmaceutical, Otsuka, AbbVie, Merck, and Eli Lilly among others.
US Dental Fluoride Treatment Market Analysis
The US Dental Fluoride Treatment Market was valued at $6,370.2 Mn in 2023 and is projected to grow at a CAGR of 1.9% from 2023 to 2023, to $7,267.3 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Procter & Gamble, Colgate Palmolive, Unilever, 3M and Ultradent Products among others.
US Chronic Pain Therapeutics Market Analysis
The US Chronic Pain Therapeutics Market is anticipated to experience a growth from $31.206 Bn in 2022 to $42.380 Bn by 2030, with a CAGR of 3.9% during the forecast period of 2022-2030. The combination of an aging population, high unmet needs, and the shift towards non-opioid options is reshaping the landscape of chronic pain therapeutics in the US. The US Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Merck, Pfizer, Sanofi, Amgen, Biogen, Teva Pharmaceuticals, etc., among various others.
US Periodontal Therapeutics Market Analysis
The US Periodontal Therapeutics Market was valued at $366.6 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $522.7 Mn by 2030. The US Periodontal Therapeutics Market is growing due to Rise in prevalence of periodontitis, Emphasis on Preventive Oral Care, and Technological Developments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
US Radiology Service Market Analysis
The US Radiology Service Market was valued at $1,680 Mn in 2023 and is predicted to grow at a CAGR of 12.7% from 2023 to 2030, to $3,879.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, geriatric population, and technological advancements. The prominent players of the US Radiology Service Market are Massachusetts General Hospital, Brigham and Women’s Hospital, University of Pittsburgh Medical Centre, John Hopkins Hospital, UCLA-Health Ronald Reagan Medical Centre, and Stanford Healthcare, among others.
US MRI Market Analysis
The US MRI Market was valued at $2788.80 Mn in 2023 and is predicted to grow at a CAGR of 4.5% from 2023 to 2030, to $3795.17 Mn by 2030. The key drivers of this industry include like increasing prevalence of chronic diseases, advancements in MRI, and medical tourism. The key players in the industry are Siemens Healthineers, Esaote North America, Rayus Radiology, and Fonar Corporation among others.
US Dental Implant Market Analysis
US Dental Implant Market was valued at $2,095.80 Mn in 2023 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to $3,545.5 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, a growing aging population, growing awareness of benefits, and improved dental technology. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
US Chronic Cough Therapeutics Market Analysis
US Chronic Cough Therapeutics Market was valued at $2646 Mn in 2022 and is estimated to reach $4249 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the high prevalence of chronic respiratory infections, as chronic cough commonly signals the presence of such conditions. Presently, leading contributors to this market comprise GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc. and Jamieson Laboratories.
US PET Scan Market Analysis
The US PET Scan Market was valued at $814.8 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $1029.7 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the US PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Hologic, Toshiba, and Canon Medical Systems, among others.
US Genomic Diagnostics Market Analysis
US Genomic Diagnostics Market was valued at $13,713 Mn in 2023 and is predicted to grow at a CAGR of 14.5% from 2023 to 2030, to $35,381.06 Mn by 2030. The key drivers of this industry include strong demand for early & preventive care, precision medicine & personalized treatments, and government funding & initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
US Conjunctivitis Therapeutics Market Analysis
The US Conjunctivitis Therapeutics Market was valued at $1.722 Bn in 2022 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $2.250 Bn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, increasing healthcare expenditure, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Allergan, Pfizer, Novartis, Santen, IBA Vision, Alembic, and Bausch & Lomb among others.
US CT Scan Market Analysis
US CT Scan market was valued at $1,936.2 Mn in 2023 and is predicted to grow at a CAGR of 5.87% from 2023 to 2030, to $2,886.43 Mn by 2030. The key drivers of this industry include the aging population, increasing cancer rates, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others
US Compression Therapy Market Analysis
US Compression Therapy Market was valued at $1596 Mn in 2022 and is estimated to reach $2118 Mn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The rising prevalence of venous disorders, including leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots, serves as a significant growth driver for the compression therapy market. Key players in this industry comprise Bauerfeind, Jobst, Medi, Sigvaris, Juzo, LympheDiv, Gibaud, Varisport, CEP, and McDavid.
US Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The US Cough Hypersensitivity Syndrome Therapeutics Market was valued at $3.402 Bn in 2022 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $4.620 Bn by 2030. The primary factors propelling this industry comprise the rising prevalence of Cough Hypersensitivity Syndrome, growing awareness, and high unmet medical needs. The industry is primarily dominated by players such as Teva, Pfizer, Vertex, Novartis, Johnson & Johnson, and GSK among others.
US Herbal Supplements Market Report
The US Herbal Supplements Market was valued at $2209.20 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $2946.52 Mn by 2030. The key drivers of this industry include increasing health consciousness, rising stress levels, and an aging population. The industry is primarily dominated by players such as Amway, Nature Made, Youtheory, Natrol, and Vitafusion among others.
US Brugada Syndrome Market Analysis
The US Brugada Syndrome Market was valued at $504 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $747.9 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the US Brugada Syndrome Market are Johnson & Johnson, Eli Lilly & Co, AbbVie, Merck & Co Inc, Pfizer, Bristol-Myers Squibb, Amgen Inc, Gilead Sciences, Medtronic, and AstraZeneca, among others.
US Clinical Nutrition for Chronic Kidney Diseases Market Analysis
US Clinical Nutrition for Chronic Kidney Diseases Market was valued at $659.40 Mn in 2023 and is predicted to grow at a CAGR of 4.03% from 2023 to 2030, to $869.50 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, growing awareness and diagnosis, advancements in medical research, and the aging population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
US Brain Cancer Therapeutics Market
US Brain Cancer Therapeutics Market valued at $966 Mn in 2022, projected to reach $1,869 Mn by 2030 with a 8.6% CAGR. A significant rise in the occurrence of brain cancer, specifically glioblastoma multiforme, is expected to drive the demand for treatments in the brain cancer therapeutics market. Top leading pharmaceutical companies currently operating in the industry are Roche, Novartis, Merck, Pfizer, BMS, Bayer, Celgene, AbbVie, Teva Pharmaceuticals, and Spectrum Pharmaceuticals.
US Dental Endodontics Market Analysis
US Dental Endodontics Market was valued at $735 Mn in 2023 and is predicted to grow at a CAGR of 2.3% from 2023 to 2030, to $861.8 Mn by 2030. The key drivers of this industry include increasing emphasis on tooth preservation, rising prevalence of dental disease, aging population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
US Blood Disorder Therapeutics Market
US Blood Disorder Therapeutics Market valued at $5.628 Bn in 2022, projected to reach $8.637 Bn by 2030 with a 5.5% CAGR. The key driver of market growth is the rising demand for personalized medicine, driven by the need for individualized treatments based on genetic and molecular profiles, leading to more precise and successful therapies with minimized side effects. The US Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda Pharmaceutical, Sanofi, Novo Nordisk, Pfizer, Bayer, CSL Behring, Grifols International, Octapharma, Xenetic Biosciences, Bristol-Myers Squibb etc, among various others.
US Bone Disease Therapeutics Market
US Bone Disease Therapeutics Market valued at $6.804 Bn in 2022, projected to reach $11.603 Mn by 2030 with a 6.9% CAGR. The key drivers of this industry include the increasing aging population of the US, technological advancements, supportive economic conditions, and others. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Eli Lilly, Novartis, Bayer, and Johnson & Johnson, among others.
US Cancer Induced Bone Disease Therapeutics Market
US Cancer Induced Bone Disease Therapeutics Market valued at $546 Mn in 2022, projected to reach $736 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include an upward trend in the incidence of cancer, an expanding therapeutic landscape, treatment advancements, and others. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Medtronic, Novartis, Fresenius, and Johnson & Johnson, among others.
US Digital Biomarkers Market Analysis
US Digital Biomarkers Market was valued at $1,218 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $4,441.26 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and patient empowerment and engagement. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
US Car T-Cell Therapy Market
US Car T-Cell Therapy Market valued at $1,218 Mn in 2022, projected to reach $1,772 Mn by 2030 with a 4.8% CAGR. The rising global cancer incidence, driven by aging populations, unhealthy lifestyles, and environmental factors, fuels an expanding population eligible for CAR T-Cell therapy, contributing to the growth of its market. Currently, leading pharmaceutical companies in this market include Gilead Sciences, Novartis, Bristol Myers Squibb, Johnson & Johnson, Kite Pharma, Legend Biotech, Celgene, Cellectis, Atara Biotherapeutics, and UCAR-T.